ArticleExperimental biology and medicine (Maywood, N.J.)2015
Teriflunomide, an immunomodulatory drug, exerts anticancer activity in triple negative breast cancer cells.
Ou Huang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this papercites it